Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
D000818:Animals; D000906:Antibodies; D000917:Antibody Formation / Q000187:drug effects; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000494:pharmacology*; D002417:Cattle / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection / Q000187:drug effects*; D007165:Immunosuppression Therapy; D008198:Lymph Nodes / Q000276:immunology; D051379:Mice; D008805:Mice, Inbred A; D008809:Mice, Inbred C3H; D011817:Rabbits / Q000276:immunology; D012710:Serum Albumin, Bovine; D012756:Sheep / Q000276:immunology; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000906:Antibodies; D000961:Antilymphocyte Serum; D012710:Serum Albumin, Bovine